Capi Vape – FDA Warning Letter
The FDA's Center for Tobacco Products issued a Warning Letter to Capivape.com after reviewing their website and determining that their e-liquid products are offered for sale or distribution in the U.S. The FDA classifies these e-liquids as tobacco products under section 201(rr) of the FD&C Act.
The primary violation identified was the sale of Bazooka Sour Straws – Watermelon e-liquid to a person younger than 18 years of age, which constitutes misbranding under section 903(a)(7)(B) of the FD&C Act. This violates 21 C.F.R. § 1140.14(b), which prohibits the sale of covered tobacco products, including e-liquids, to minors.
Capivape.com is required to immediately correct this violation and similar issues, ensuring all tobacco products and related advertising comply with the FD&C Act and FDA regulations. Failure to comply may result in civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. A written response detailing corrective actions, including discontinuation dates of violative sales/advertising and a compliance plan, must be submitted within 15 working days.
- Company
- Capi Vape
- Product type
- Tobacco
ID · 4d87485c-07cc-437a-8ede-9f31f57870d4
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.